Starting April 1, 2025, Asahi Kasei Medical Co., Ltd. began operating as a new company focused on medical devices.
Additionally, the Bioprocess Business was transferred to Asahi Kasei Life Science on the same date.

Blood Purification

Providing treatment to more patients through hemodialysis and therapeutic apheresis technology.

• Business domain

Intensive Care

Contributing to the resolution of diverse and complex challenges in intensive care through cutting-edge solutions in the world.

• Business domain

Autologous Blood

Using Autologous Blood and Improving Safety and Quality of Healthcare.

• Business domain

• View

April 1,2025

Our company has appointed new executives and began operating as a new company focused on medical devices.

November 1, 2024

Asahi Kasei Medical Co., Ltd. Announces Launch of "TrachFlush® in Japan"

Mar 28, 2024

Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan

June 10, 2022

Please be careful about suspicious emails disguised as Asahi Kasei Medical

Introducing treatment options and the approach of Asahi Kasei Medical.

• Blood and Blood therapies
• About therapies